SC NOTICE TO CENTRE AND CHRISTIAN MEDICAL COLLEGE ON INFANTS DEATH BY DIARRHOEA; CAUSED BY ROTAVAC VACCINE

  • News
  • July 15, 2016

New Delhi – Supreme Court issued a notice on Tuesday to Centre and CMC, Vellore on a PIL demanding complete information on clinical trial results of Rotavac, an anti-diarrhoeal vaccine for Rotavirus conducted between 2011 and 2013 at Delhi, Pune and Vellore. Rotavirus vaccine was launched officially on March 26 by Ministry of Health to reduce the deaths caused by diarrhoea in infants.

A phase III clinical trial was conducted before launching vaccine to measure the safety and efficacy parameters for protecting infants from viruses, which are the cause for severe diarrhoea in them. Justice Madan B Lokur and RK Agarwal and Medical College have issued notices to Ministry of health and family welfare & Department of bio-technology of the Ministry of Science and technology on plea filed by S Srinivasan, managing trustee of “LOCOST” (Low Cost Standard Therapeutics) based in Vadodara, Gujarat .

The plea sought direction to Centre and others to disclose to the public “segregated data” on the phase III clinical trial results of ‘Rotavac’ involving 6,799 infants. Prashant Bhushan, advocate who filed plea said that disclosing the segregated data was crucial to know if the vaccine is safe in all areas or some groups are more susceptible to adverse effects of vaccine. The plea further stated that data should have been examined by National Technical Advisory Group on Immunization (NTAGI) in “public interest but such is the secrecy surrounding it, it has not been provided even to this apex body”.

It also needed a direction to frame guidelines regarding disclosing the complete segregated results on clinical trials on humans according to a WHO statement on April 2015 on the issue. The plea urged the apex court to set aside the order given by Delhi High Court on October, 2015 to dismiss the plea to hold back the Centre on further conducting any clinical trials for rotavirus vaccine in India. The high court order had come on a plea filed by Dr.Jacob Puliyel, NTAGI member, stating to hold back the government from conducting phase IV trials where over 1Lakh children would be given the vaccine.

Related Posts

‘A Knight in Shining Armor’ packed a punch in FOGSI for Gender Equality

New Delhi: There was no fog in sight; FOGSI was shining as never before, thanks to the leadership of its outgoing president Dr Hrishikesh Pai. The over 40, 000 strong…

  • News
  • December 16, 2023
  • 7 views
Women are on Trajectory to make Presence Felt in Healthcare India

New Delhi: It could be advantage patients in times to come as women as workforce are increasing in healthcare domain of India. It is given that women power blended with…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

Lee Health develops natural capsule for effective Heart care

Lee Health develops natural capsule for effective Heart care

Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down

Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down